AMCP Format 4.1 Teaser Image

AMCP Format for Formulary Submissions — Guidance on Submission of Pre-Approval and Post-Approval Clinical and Economic Information and Evidence, Version 4.1

The aim of the AMCP Format is to identify comprehensive evidence and information elements that meet the evidentiary needs of HCDMs. The AMCP Format is designed to encourage sharing of objective, credible, and relevant information on medical products.
Formulary & Utilization Management, Format for Formulary Submissions
AMCP Podcast Series Featured Episode

Fundamentals of Managed Care Pharmacy Training Program

Host Fred Goldstein invites Ruby Singh, Senior Vice President of Education and Instruction and Brittany Henry, Director of Education Programs, with AMCP, to discuss the brand-new 3rd edition of the AMCP Fundamentals of Managed Care Pharmacy Training Program scheduled for release July 2023.
AMCP Podcast Series Featured Episode

AMCP Format for Formulary Submissions v4.1 Revisions: Public Comment Period

Don't miss out on your chance to comment! Health care expert Fred Goldstein sits down with Ellen Whipple, BS Pharm, PharmD, to discuss the AMCP Format revision focused on digital therapeutics, health disparities, real-world evidence, PIE Deck guidance, and streamlining dossier development.
AMCP Podcast Series Featured Episode

Capitol Hill PBM Reforms

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent action on Capitol Hill surrounding pharmacy benefit manager reform.

AMCP Volunteer Spotlight: Matt Moen

AMCP's volunteers are vital players in propelling our mission forward. In this installment of the AMCP Volunteer Spotlight, we are featuring Matt Moen, PharmD, MBA, AMCP Membership Committee member.   
AMCP Membership
AMCP Podcast Series Featured Episode

Unpacking the CMS Guidance on Drug Negotiation, Part 2

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent CMS guidance on drug price negotiation for 2026.